dehydrorableomycin methyl ether | 326803-16-1

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 角环素
• 英文名称: dehydrorableomycin methyl ether
• 英文别名: 8-methoxydehydrorabelomycin；1,6-Dihydroxy-8-methoxy-3-methylbenzo[a]anthracene-7,12-dione
• CAS: 326803-16-1
• 化学式: C₂₀H₁₄O₅
• 分子量: 334.328
• InChiKey: RURIIOWJNJUPJL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.3
• 重原子数：
  25
• 可旋转键数：
  1
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  83.8
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  dehydrorableomycin methyl ether 在 三氯化铝 、 乙硫醇 、 盐酸 、 air 作用下， 反应 2.0h， 以90%的产率得到dehydrorabelomycin
  参考文献：
  名称：

  A General Approach to Angucyclines: Synthesis of Hatomarubigin A, Rubiginone B2, Antibiotic X-1488E, 6-Hydroxytetrangulol, and Tetrangulol

  摘要：

  Hatomarubigin A was prepared in 41% yield in a single procedure from acyl naphthoquinone 15 and 5-methylcyclohexane-1,3-dione (16). The net reaction consists of Michael addition to an acyl quinone followed by intramolecular aldol condensation. Hatomarubigin A then served as a common intermediate in syntheses of the angucyclinone antibiotics rubiginone B2, antibiotic X-1488E, 6-hydroxy-tetrangulol, and tetrangulol. (C) 2000 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0040-4020(00)00869-3
• 作为产物：
  描述：

  3-acetyl-5-methoxy-1,4-naphthoquinone 在 sodium hydroxide 、 乙醇 、 palladium diacetate 、 sodium hydride 、 三乙胺 作用下， 以 乙醇 、 水 、 N,N-二甲基甲酰胺 、 乙腈 为溶剂， 反应 33.0h， 生成 dehydrorableomycin methyl ether
  参考文献：
  名称：

  A General Approach to Angucyclines: Synthesis of Hatomarubigin A, Rubiginone B2, Antibiotic X-1488E, 6-Hydroxytetrangulol, and Tetrangulol

  摘要：

  Hatomarubigin A was prepared in 41% yield in a single procedure from acyl naphthoquinone 15 and 5-methylcyclohexane-1,3-dione (16). The net reaction consists of Michael addition to an acyl quinone followed by intramolecular aldol condensation. Hatomarubigin A then served as a common intermediate in syntheses of the angucyclinone antibiotics rubiginone B2, antibiotic X-1488E, 6-hydroxy-tetrangulol, and tetrangulol. (C) 2000 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0040-4020(00)00869-3

文献信息

• METHODS, COMPOSITIONS, AND KITS FOR THE TREATMENT OF CANCER
  申请人：Haggerty Timothy J.

  公开号：US20140335050A1

  公开（公告）日：2014-11-13

  The invention features methods, compositions, and kits for the administration of an HSP90 inhibitor, OBAA, flunarizine, aphidicolin, damnacanthal, dantrolene, or an analog thereof, alone, or in combination with, e.g., a TAA, an antigen-binding scaffold (e.g., an antibody, a soluble T cell receptor, or a chimeric receptor) specific for a TAA, a cell (e.g., a white blood cell that targets a cancer cell), and/or an IFN-β receptor agonist or an IFN-γ receptor agonist, for the treatment of cancer.
• A General Approach to Angucyclines: Synthesis of Hatomarubigin A, Rubiginone B2, Antibiotic X-1488E, 6-Hydroxytetrangulol, and Tetrangulol
  作者：Kathlyn A Parker、Qing-jie Ding

  DOI：10.1016/s0040-4020(00)00869-3

  日期：2000.12

  Hatomarubigin A was prepared in 41% yield in a single procedure from acyl naphthoquinone 15 and 5-methylcyclohexane-1,3-dione (16). The net reaction consists of Michael addition to an acyl quinone followed by intramolecular aldol condensation. Hatomarubigin A then served as a common intermediate in syntheses of the angucyclinone antibiotics rubiginone B2, antibiotic X-1488E, 6-hydroxy-tetrangulol, and tetrangulol. (C) 2000 Elsevier Science Ltd. All rights reserved.